Professor Muhammad Adnan Khattak
Clinical Professor Adnan Khattak works as a Consultant Medical Oncologist at Fiona Stanley Hospital (FSH) and SJOG Subiaco/Murdoch. He did his initial specialist training in Adelaide before going to the UK where he worked as a Clinical Research Fellow in the melanoma unit at the prestigious Royal Marsden Hospital in London.
Prof Khattak is an active researcher, with interests in melanoma and cancer immunotherapy. He is the Director of Medical Oncology Clinical Trials Unit at FSH and the Primary Investigator of many International/National clinical trials. He strongly encourages his patients to participate in clinical trials and has vast experience in using novel anti-cancer therapies.
He has more than 40 publications at this stage in various peer reviewed journals including the New England Journal of Medicine, the Lancet Oncology, Journal of Clinical Oncology and European Journal of Cancer. He has presented his research at a number of National and International scientific meetings. He has been invited as an International visiting speaker to the US, Hong Kong, Taiwan, Saudi Arabia, China, Singapore and Malaysia. His current research projects include blood-based biomarkers (circulating tumour cells and circulating tumour DNA) of response & resistance to immunotherapy in cancer.
He is the recipient of a number of prestigious research awards including Cancer Council WA Suzanne Cavanagh Young Investigator Award, Raine Foundation Research Fellowship, Spinnaker Health Research Foundation award, MSD Young Investigator award, NHMRC Developmental grant and Royal Perth Hospital Medical Research Foundation Award. He is the Chief Investigator/Associate Investigator of research grants in excess of A$2,500,000.